From the left, MyOneFarm CEO Lee Young-jin, Humedics CEO Kim Jin-hwan.

From the left, MyOneFarm CEO Lee Young-jin, Humedics CEO Kim Jin-hwan.

View original image


[Asia Economy Reporter Lee Gwan-joo] Humedix announced on the 21st that it has signed a cosmetics supply contract with MyOnePharm and is embarking on a full-scale entry into the Japanese cosmetic market.


The products covered by the supply contract include 17 items such as Derma Elavie’s flagship products, First Essence Skin and Balancing Fluid. By combining hyaluronic acid as the key ingredient with pharmaceutical and bio-polymer application technologies, these products help maintain skin balance. The initial shipment of the first batch is scheduled for next month.


Through this contract, Humedix expects to expand trust and influence in Derma Elavie products. The company plans to actively utilize the distribution network of the medical specialty shopping mall MyOnePharm to broaden the global presence of Derma Elavie products and achieve stable sales.



A Humedix official said, "After meticulous preparations between the two companies since March, we have reached the contract signing. We are pleased to be on the main track for entering the Japanese market," adding, "Based on Humedix’s innovative technology and competitiveness, we will achieve remarkable results in the Japanese market with a more differentiated product lineup."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing